國立高雄大學圖資館 |

Language: English

Back

Accelerated path to cures

Bassaganya-Riera, Josep.

Accelerated path to cures

Record Type:	Electronic resources : Monograph/item
Title/Author:	Accelerated path to curesedited by Josep Bassaganya-Riera.
other author:	Bassaganya-Riera, Josep.
Published:	Cham :Springer International Publishing :2018.
Description:	viii, 82 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Immunology.
Online resource:	http://dx.doi.org/10.1007/978-3-319-73238-1
ISBN:	9783319732381$q(electronic bk.)

Accelerated path to cures
Accelerated path to cures[electronic resource] /edited by Josep Bassaganya-Riera. - Cham :Springer International Publishing :2018. - viii, 82 p. :ill., digital ;24 cm.

Chapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease -- Chapter 2: Computer-Aided Drug Discovery -- Chapter 3: Preclinical Studies: Efficacy and Safety -- Chapter 4: From Nutritional Immunology to Drug Development -- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.

Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures.

ISBN: 9783319732381$q(electronic bk.)

Standard No.: 10.1007/978-3-319-73238-1doiSubjects--Topical Terms:

189152
Immunology.

LC Class. No.: QR182.2.I46 / A234 2018

Dewey Class. No.: 616.0790285

Accelerated path to cures
LDR:02481nmm a2200313 a 4500 001 537596
003 DE-He213
005 20181105164749.0
006 m d
007 cr nn 008maaau
008 190116s2018 gw s 0 eng d
020 $a 9783319732381$q(electronic bk.)
020 $a 9783319732374$q(paper)
024 7 $a 10.1007/978-3-319-73238-1 $2 doi
035 $a 978-3-319-73238-1
040 $a GP $c GP
041 0 $a eng
050 4 $a QR182.2.I46 $b A234 2018
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 616.0790285 $2 23
090 $a QR182.2.I46 $b A169 2018
245 0 0 $a Accelerated path to cures $h [electronic resource] / $c edited by Josep Bassaganya-Riera.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a viii, 82 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease -- Chapter 2: Computer-Aided Drug Discovery -- Chapter 3: Preclinical Studies: Efficacy and Safety -- Chapter 4: From Nutritional Immunology to Drug Development -- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.
520 $a Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures.
650 0 $a Immunology. $3 189152
650 0 $a Immunoinformatics. $3 224310
650 0 $a Drug development. $3 190608
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Computational Biology/Bioinformatics. $3 274833
650 2 4 $a Health Informatics. $3 274212
650 2 4 $a Computer Appl. in Life Sciences. $3 274180
700 1 $a Bassaganya-Riera, Josep. $3 814629
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-73238-1
950 $a Biomedical and Life Sciences (Springer-11642)